Dr. Amin Ahmed Ramzan, MD

Dr. Ramzan practices at Kern County Hospital Authority in Bakersfield, California.

Dr. Ramzan's NPI, 1932530714, was assigned on December 4, 2013. Dr. Ramzan graduated from Keck School of Medicine of USC in 2012. Dr. Ramzan holds California license A127936.

Dr. Ramzan's primary practice is Kern County Hospital Authority, at 1700 Mt Vernon Ave, Bakersfield, CA 93306 in Kern County. The practice phone is (661) 326-2000.

Dr. Ramzan's primary practice is Kern County Hospital Authority in Bakersfield, California. Dr. Ramzan is also affiliated with Adventist Health Bakersfield. The medical group on file is Kern Medical. Dmand AI also links Dr. Ramzan to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ramzan practices, 2 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Ramzan's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Ramzan is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Ramzan's licenses on file in 2 states: California and Colorado.

Dmand AI lists hysterectomy and vaginal infection among the conditions Dr. Ramzan treats.

CMS data shows 190 Medicare services from Dr. Ramzan across 4 procedure codes in 2024, for 74 Medicare patients. Medicare paid $9,946 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 74 Medicare patients who saw Dr. Ramzan in 2024. The largest group is 65 to 74, with 36 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 59% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ramzan's median patient age at 59, with 99% women.

In 2024, Dr. Ramzan wrote 54 Medicare Part D claims for 21 patients. 78% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $227 in total drug cost. In 2019, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Ramzan for performance year 2024, reported as part of a group. Dr. Ramzan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ramzan as offering telehealth.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Ramzan, published from 2015 to 2020. 2018 was the busiest year, with 5. The most frequent topics are Genital Neoplasms, Female, Gynecology and Analgesics, Opioid. Dr. Ramzan has published most often in Gynecol Oncol. Dr. Ramzan's most frequent co-authors are Carolyn Joy Casey Lefkowits, MD, MPH, Renata Rose Urban, MD and Saketh Ram Guntupalli, MD.

CMS Open Payments shows 79 general payments to Dr. Ramzan from 33 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 62% of the total. Medical Device Business Services, Inc. paid the most, $1,054.

Dr. Ramzan graduated from Keck School of Medicine of USC in 2012. Dr. Ramzan is a member of American College of Obstetricians and Gynecologists.

Dr. Ramzan is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.